| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
|
| | (4aS,7aS)-octahydrocyclopenta[b][1,4]oxazine Basic information |
| Product Name: | (4aS,7aS)-octahydrocyclopenta[b][1,4]oxazine | | Synonyms: | (4aS,7aS)-Octahydrocyclopenta[b]morpholine;(4aS,7aS)-octahydrocyclopenta[b][1,4]oxazine;Cyclopent[b]-1,4-oxazine, octahydro-,(4aS,7aS)-;(4aS,7aS)-Octahydrocyclopent[b]-1,4-oxazine | | CAS: | 1542269-05-5 | | MF: | C7H13NO | | MW: | 127.18 | | EINECS: | | | Product Categories: | | | Mol File: | 1542269-05-5.mol | ![(4aS,7aS)-octahydrocyclopenta[b][1,4]oxazine Structure](CAS/20200119/GIF/1542269-05-5.gif) |
| | (4aS,7aS)-octahydrocyclopenta[b][1,4]oxazine Chemical Properties |
| Boiling point | 198.9±15.0 °C(Predicted) | | density | 0.995±0.06 g/cm3(Predicted) | | pka | 9.18±0.20(Predicted) |
| | (4aS,7aS)-octahydrocyclopenta[b][1,4]oxazine Usage And Synthesis |
| | (4aS,7aS)-octahydrocyclopenta[b][1,4]oxazine Preparation Products And Raw materials |
|